Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Multiple Myeloma : Translational and Emerging Therapies, Hardback Book

Multiple Myeloma : Translational and Emerging Therapies Hardback

Edited by Kenneth C. Anderson, Irene Ghobrial

Part of the Translational Medicine series

Hardback

Description

Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year.

This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel therapeutic options for patients with myeloma. Moving from the bench to the bedside to the forefront of therapeutic development, this source:helps clinicians and researchers effectively deploy therapeutic strategies into clinical practicereflects trends in the use of agents which target both the tumor cell and its bone marrow microenvironment to overcome resistance to conventional therapiesconsiders the critical role of the bone marrow microenvironment in the regulation of growth, survival, and homing of multiple myelomadiscusses novel therapies in phase I and phase II trials, focusing specifically on therapeutic options for patients with newly diagnosed or relapsed/refractory multiple myelomaaddresses novel therapies for other plasma cell disorders, and provides the framework for the design of next generation agents and combination therapiescovers the entire scope of translational work in multiple myeloma, from advances in molecular pathogenesis, to prognostic factors, immunotherapy, and new options for newly diagnosed and relapsed multiple myeloma patients

Information

  • Format:Hardback
  • Pages:320 pages, 16 Tables, black and white; 3 Halftones, black and white; 50 Illustrations, color; 18 Ill
  • Publisher:Taylor & Francis Inc
  • Publication Date:
  • Category:
  • ISBN:9781420045109
Save 0%

£77.99

£77.95

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

  • Format:Hardback
  • Pages:320 pages, 16 Tables, black and white; 3 Halftones, black and white; 50 Illustrations, color; 18 Ill
  • Publisher:Taylor & Francis Inc
  • Publication Date:
  • Category:
  • ISBN:9781420045109

Also in the Translational Medicine series  |  View all